Nuvation Bio Inc.
Status: Publicly traded
Direct answer
Nuvation Bio Inc. is publicly traded on NYSE under the ticker NUVB.
Nuvation Bio Inc. functions as a clinical-stage biopharmaceutical enterprise committed to discovering and advancing therapeutic solutions for oncological conditions. Its foremost experimental compound, NUV-422, is a small molecule designed to inhibit cyclin-dependent kinases (CDK)2, CDK4, and CDK6. The company's development pipeline further encompasses NUV-868, an orally administered, selective small molecule BET...
Can you invest in Nuvation Bio Inc.?
Yes. Nuvation Bio Inc. is publicly traded on NYSE under the ticker NUVB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nuvation Bio Inc.
Detailed equity research is provided by MarketSnap.